It is known that RA patients with increased serum levels of RF or ACPA are at higher risk of joint damage and a more severe disease course compared with seronegative patients [43], and in seropositive patients, the related autoantibodies develop years before RA diagnosis [44]. Here, PRTN3 is linked to rheumatoid arthritis.